SCHEMBL18683299

SCHEMBL18683299

OCCC(CF)c1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
IDO1 P14902 2/20 0.37
TDO2 P48775 2/20 0.37
CNR2 P34972 2/20 0.36
CYP3A4 P08684 4/20 0.34
GAA P10253 1/20 0.33
SLC6A2 P23975 4/20 0.32
SLC6A4 P31645 4/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
OPRL1 P41146 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24877434 0.77 CES2 (0.42) CES2CES1IDO1TDO2CNR2
SCHEMBL3186857 0.76 CES2 (0.43) CES2CES1IDO1TDO2CNR2
SCHEMBL28830478 0.76 CES2 (0.36) CES2CES1IDO1TDO2CNR2
SCHEMBL28830480 0.76 CES2 (0.36) CES2CES1IDO1TDO2CNR2
SCHEMBL18683038 0.75 DGAT1 (0.32) SLC6A4CYP2D6
SCHEMBL28982438 0.74 CES2 (0.38) CES2CES1IDO1TDO2CNR2
SCHEMBL3385586 0.74 IDO1 (0.41) CES2CES1IDO1TDO2CNR2
SCHEMBL20445808 0.74 IDO1 (0.41) CES2CES1IDO1TDO2CNR2
SCHEMBL18683363 0.74 EEF2K (0.46) CES2CES1CNR2GAAMEN1
SCHEMBL23489941 0.71 CES2 (0.46) CES2CES1IDO1TDO2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353163-B1 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2020-02-05 EP disclosed
WO-2017050978-A1 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-30 WO disclosed